AMICUS THERAPEUTICS, INC. — Director's Dealing 2019

Jul 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2019-06-27

Reporting Person: WHITMAN BURKE W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-27	Common Stock	A	16667	$0.00	Acquired	16667	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-27	Stock Options (right to buy)	$12.00	A	25964	Acquired	2029-06-27	Common Stock (25964)	Direct

Footnotes

F1: These restricted stock units (RSUs) vest in a series of installments over a four year period with 25% vesting each year upon the anniversary of the grant.

F2: These stock options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the vesting commencement date and the remainder vesting ratably each month thereafter in equal installments over a three year period.